No Data
Zhongxing Bacteria: 2024 Annual Report Summary
Zhongxing Bacteria Industry: 2024 Annual Report
Tianshui Zhongxing Bio-technology Approves Subsidiary's Facility Upgrade
Tianshui Zhongxing Bio-technology (002772.SZ) plans to implement a 0.123 billion yuan project for the industrialized bionic cultivation and renovation of Cordyceps sinensis.
Tianshui Zhongxing Bio-technology (002772.SZ) announced that in order to improve the company's diversified Business layout and enhance the company's core competitiveness...
Tianshui Zhongxing Bio-technology (002772.SZ) has repurchased a total of 4.5868% of its shares at a cost of approximately 0.14 billion yuan.
Tianshui Zhongxing Bio-technology (002772.SZ) announced that as of January 31, 2025, the company has completed the buyback of its shares...
Tianshui Zhongxing Bio-technology (002772.SZ): has repurchased a total of 2.022% of its shares.
Gelonghui reported on December 18 that Tianshui Zhongxing Bio-technology (002772.SZ) announced that as of December 18, 2024, the company has repurchased a total of 7,951,326 shares through a special repurchase securities account via centralized bidding transactions, accounting for 2.0220% of the company's total equity. The highest Fill Price was 8.00 yuan/share, the lowest Fill Price was 7.34 yuan/share, and the total amount paid was 61.2229 million yuan (excluding transaction fees, etc.).
Benign Growth For Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Underpins Stock's 25% Plummet
